Results for:(15 found)
May 9, 2013 10:46AM on Top StocksBy TheStreet Staff

The supplement has no heart benefits for patients, which doesn't bode well for the drug company's efforts to market Vascepa.

Mar 20, 2013 10:38AM on Top StocksBy MSN Money Partner

Zynga is downgraded to 'neutral,' and The Fresh Market is initiated with a 'strong buy.'

Feb 28, 2013 12:09PM on Top StocksBy TheStreet Staff

Pfizer has multiple health care businesses and Elan has Tysabri royalties and a would-be acquirer.

Feb 4, 2013 12:37PM on Top StocksBy TheStreet Staff

A report questions whether the FDA will grant New Chemical Entity status for the phosphate binder.

Jan 28, 2013 12:15PM on Top StocksBy TheStreet Staff

The company's fish-oil pill is finally on pharmacy shelves 6 months after approval.

Jan 2, 2013 12:07PM on Top StocksBy TheStreet Staff

TheStreet's Adam Feuerstein gazes into his crystal ball to offer his biotechnology forecast for the new year.

Dec 7, 2012 2:23PM on Top StocksBy MSN Money Partner

Stocks pare earlier gains and turn mixed after the consumer sentiment survey disappoints.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

SMART SPENDING

More

SMART TAXES

More